Renal Cell Carcinoma

Introduction - Rini/Campbell 1: Pathology - (Zhou, CCF) 2: Epidemiology and Screening of RCC (Godley) 3: Diagnosis and Management of Inherited RCC(Nathanson/Stephenson) 4: Genetics of Sporadic RCC (Bin Teh) 5: Imaging Techniques (Herts) 6: Management of Small Renal Masses a: Biopsy (Uzzo) b: Non-invasive Techniques (Matin) c: Partial Nephrectomy (Novick) 7: Prognostic Factors in Localized RCC (Pantuc, Belldegrun) 8: Radical Nephrectomy for Localized RCC (Samir Taneja - NYU) 9: Surgical Management of Locally-Advanced RCC (Wood) 10: Adjuvant Therapy in RCC (Eisen-Caimbridge) 11: Prognostic Factors in Metastatic RCC (Choueiri-CCF) 12: Immunobiology of Metastatic RCC (Jim Finke - CCF) 13: Immunotherapy in Metastatic RCC (David McDermott - BI) 14: Angiogenesis Biology in Metastatic RCC (Kim Rathmell - UNC) 15: Anti-VEGF Therapy in Metastatic RCC a: VEGF Ligand-binding Agents (Rini/Rathmell) b: Therapeutic Inhibition of VEGF Receptor (Oliver Rixe - France) 16: Akt Pathway Biology in Metastatic RCC (Dan George - Duke) 17: Therapeutic mTOR Inhibition in Metastatic RCC (Gary Hudes - FCCC) 18: Future Therapeutics in Metastatic RCC (Keith Flaherty - Penn) 19: Surgical Management of Metastatic RCC (Evans, Rini and Campbell) 20: Supportive Care in Metastatic RCC a: Biphosphonates (Michelson - MGH) b: Management of CNS Metastases (Hutson - Baylor) c: Palliative Care Considerations (Davis - CCF)

Brian I. Rini, MDAssociate ProfessorDepartment of Solid Tumor Oncology and UrologyCleveland Clinic Taussig Cancer CenterAssociate Professor of MedicineCleveland Clinic Foundation/ Case Western Reserve University Lerner College of MedicineCleveland, OH Steven C. Campbell, MD, PhDProfessor of SurgerySection of Urological OncologyGlickman Urological InstituteCleveland Clinic FoundationCleveland OH